Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease.
作者信息
Dufour Carlo, Cappelli Barbara, Calvillo Michaela, Fioredda Francesca, Tonelli Rossella, Crocchiolo Roberto
出版信息
Haematologica. 2010 Apr;95(4):684-5. doi: 10.3324/haematol.2009.018333. Epub 2010 Jan 6.
Abstract
摘要
相似文献
1
Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease.不同年龄和基础疾病患者中聚乙二醇化重组人粒细胞刺激因子过量使用的类似良好结局。
Haematologica. 2010 Apr;95(4):684-5. doi: 10.3324/haematol.2009.018333. Epub 2010 Jan 6.
2
Overdose of pegfilgrastim: case report.培非格司亭用药过量：病例报告。
Int J Clin Pharm. 2012 Oct;34(5):690-2. doi: 10.1007/s11096-012-9653-z. Epub 2012 Jul 21.
3
Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study.培格非格司亭和每日粒细胞集落刺激因子：西班牙癌症患者的使用模式和中性粒细胞减少相关结局——LEARN 研究结果。
Eur J Cancer Care (Engl). 2009 May;18(3):280-6. doi: 10.1111/j.1365-2354.2008.00959.x. Epub 2008 Dec 8.
4
Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim.糖原贮积病I型b型慢性中性粒细胞减少症患者的呼吸窘迫和猝死：培非格司亭的可能作用
Haematologica. 2009 Aug;94(8):1175-7. doi: 10.3324/haematol.2008.005330.
5
Pegfilgrastim.聚乙二醇化重组人粒细胞刺激因子
Drugs. 2002;62(8):1207-13; discussion 1214-5. doi: 10.2165/00003495-200262080-00012.
6
Once-per-cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma.尤文肉瘤患儿中每周期一次聚乙二醇化重组人粒细胞刺激因子与每日一次重组人粒细胞刺激因子的对比研究
J Pediatr Hematol Oncol. 2005 Aug;27(8):449-51. doi: 10.1097/01.mph.0000175711.73039.63.
7
Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.与粒细胞集落刺激因子（G-CSF）相比，培非格司亭支持含剂量密集、快速循环抗代谢物的化疗方案（Hyper-CVAD）用于治疗淋巴系统恶性肿瘤的安全性和有效性。
Leuk Lymphoma. 2006 Sep;47(9):1813-7. doi: 10.1080/10428190600632832.
8
Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy.培非格司亭在接受骨髓抑制性化疗患者中的安全性和有效性。
Pharmacotherapy. 2003 Aug;23(8 Pt 2):15S-19S. doi: 10.1592/phco.23.9.15s.32889.
9
Pegfilgrastim.聚乙二醇化重组人粒细胞刺激因子
Expert Opin Biol Ther. 2002 Dec;2(8):985-92. doi: 10.1517/14712598.2.8.985.
10
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.单剂量培非格司亭与每日使用非格司亭用于支持低至中危急性髓系白血病患者中性粒细胞恢复的比较：一项随机、双盲、2期试验的结果
BMC Cancer. 2008 Jul 10;8:195. doi: 10.1186/1471-2407-8-195.
引用本文的文献
1
Assessing the Optimal Regimen: A Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Long-Acting Granulocyte Colony-Stimulating Factors in Patients with Breast Cancer.评估最佳方案：对乳腺癌患者长效粒细胞集落刺激因子疗效与安全性的系统评价和网状荟萃分析
Cancers (Basel). 2023 Jul 19;15(14):3675. doi: 10.3390/cancers15143675.
2
Overdose of pegfilgrastim: case report.培非格司亭用药过量：病例报告。
Int J Clin Pharm. 2012 Oct;34(5):690-2. doi: 10.1007/s11096-012-9653-z. Epub 2012 Jul 21.
本文引用的文献
1
Pegfilgrastim in children with severe congenital neutropenia.培格非格司亭在严重先天性中性粒细胞减少症儿童中的应用。
Pediatr Blood Cancer. 2010 Mar;54(3):465-7. doi: 10.1002/pbc.22350.
2
Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim.糖原贮积病I型b型慢性中性粒细胞减少症患者的呼吸窘迫和猝死：培非格司亭的可能作用
Haematologica. 2009 Aug;94(8):1175-7. doi: 10.3324/haematol.2008.005330.
3
Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.培非格司亭在先天性中性粒细胞减少症中是否安全有效？对法国严重慢性中性粒细胞减少症登记处的分析。
Pediatr Blood Cancer. 2009 Dec;53(6):1068-73. doi: 10.1002/pbc.22147.
4
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.与未缀合的粒细胞集落刺激因子相比，聚乙二醇化粒细胞集落刺激因子动员具有不同干细胞和祖细胞亚群以及不同功能特性的CD34+细胞。
Haematologica. 2008 Mar;93(3):347-55. doi: 10.3324/haematol.12081. Epub 2008 Feb 11.
5
Serum pegfilgrastim concentrations during recovery of absolute neutrophil count in patients with cancer receiving pegfilgrastim after chemotherapy.接受化疗后使用培非格司亭的癌症患者在绝对中性粒细胞计数恢复过程中的血清培非格司亭浓度。
Pharmacotherapy. 2007 Oct;27(10):1387-93. doi: 10.1592/phco.27.10.1387.
6
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.意大利淋巴瘤研究小组开展的一项随机研究的长期结果，该研究比较了Mini-CEOP与P-VEBEC方案在老年弥漫性大B细胞淋巴瘤患者中的疗效。
Leuk Lymphoma. 2007 Feb;48(2):367-73. doi: 10.1080/10428190601078100.
7
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.一项关于接受骨髓抑制性化疗的患者中，固定剂量单次给药聚乙二醇化非格司亭与每日注射非格司亭对比的随机双盲多中心III期研究。
Ann Oncol. 2003 Jan;14(1):29-35. doi: 10.1093/annonc/mdg019.
8
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.化疗所致中性粒细胞减少症中，每周期一次的聚乙二醇化重组人粒细胞刺激因子与每日注射重组人粒细胞刺激因子的疗效和安全性比较：一项针对乳腺癌女性患者的多中心剂量探索性研究。
Ann Oncol. 2002 Jun;13(6):903-9. doi: 10.1093/annonc/mdf130.
9
Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications.
Leukemia. 1997 Apr;11(4):466-78. doi: 10.1038/sj.leu.2400607.
10
Impairment in gas exchange after granulocyte colony stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome.成年呼吸窘迫综合征患者使用粒细胞集落刺激因子（G-CSF）后气体交换受损。
Chest. 1995 Jan;107(1):276-8. doi: 10.1378/chest.107.1.276.
Zotero 插件